Search
Search Results
-
Urine cell-free DNA multi-omics to detect MRD and predict survival in bladder cancer patients
Circulating tumor DNA (ctDNA) sensitivity remains subpar for molecular residual disease (MRD) detection in bladder cancer patients. To remedy this...
-
Whole body FDG PET/MR for progression free and overall survival prediction in patients with relapsed/refractory large B-cell lymphomas undergoing CAR T-cell therapy
BackgroundTo find semi-quantitative and quantitative Positron Emission Tomography/Magnetic Resonance (PET/MR) imaging metrics of both tumor and...
-
-
Impact of antigen identification on transplant free survival in interstitial lung disease
IntroductionAntigen identification impacts diagnosis as well as prognosis in patients with hypersensitivity pneumonitis. An antigen may also be...
-
Computed tomography-based radiomics signature as a pretreatment predictor of progression-free survival in locally advanced hypopharyngeal carcinoma with a different response to induction chemotherapy
PurposeTo establish and validate a radiomics signature for stratifying the risk of progression-free survival (PFS) in patients with locally advanced...
-
ARID1A mutation associated with recurrence and shorter progression-free survival in atypical meningiomas
PurposeThe oncologic outcomes for atypical meningiomas can be poor. Generally, patients that have had a prior recurrence have a substantially...
-
-
Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
ObjectiveThis investigation aimed to explore the relationship between sarcopenia and severe postoperative complications, relapse-free survival (RFS),...
-
LINC00844 suppresses tumor progression and predicts survival outcomes through inhibiting miR-19a-5p in cholangiocarcinoma
BackgroundCholangiocarcinoma (CCA) is a heterogeneous malignancy. The aim of the study was to investigate the regulatory role of long noncoding RNA...
-
A machine learning approach applied to gynecological ultrasound to predict progression-free survival in ovarian cancer patients
In a growing number of social and clinical scenarios, machine learning (ML) is emerging as a promising tool for implementing complex multi-parametric...
-
Impact of dose escalation on colostomy-free survival and treatment outcome in squamous cell anal carcinoma
PurposePrimary radiochemotherapy (RCT) constitutes the standard of care for early- and advanced-stage anal carcinoma. This retrospective study...
-
Development and External Validation of Nomograms for Predicting Disease-Free Survival and Overall Survival in Patients with cT1-ccRCC After Partial Nephrectomy: A Multicenter Retrospective Study
BackgroundTo develop a novel nomogram for predicting 2-year and 5-year disease-free survival (DFS) and overall survival (OS) in patients with...
-
Real-world progression-free survival (rwPFS) and the impact of PD-L1 and smoking in driver-mutated non-small cell lung cancer (NSCLC) treated with immunotherapy
PurposePrior data suggest driver-mutated NSCLC, especially EGFR and ALK tumors, poorly respond to immunotherapy. However, little research using...
-
-
Radiological Shape of the Tumor Predicts Progression and Survival in Resected Extrahepatic Cholangiocarcinoma
BackgroundThe histological features and radiological shape of extrahepatic cholangiocarcinoma (eCCA) have not been widely studied in relation to...
-
Autonomic dysfunction is associated with disease progression and survival in amyotrophic lateral sclerosis: a prospective longitudinal cohort study
BackgroundAmong non-motor symptoms, autonomic disturbances have been described in amyotrophic lateral sclerosis (ALS) and reported as mild to...
-
MicroRNA-21 expression in cancer cells is an independent biomarker of progression-free survival of endometrioid endometrial carcinoma
Endometrial carcinoma is one of the most common gynecological cancers. MicroRNA-21 (miR-21) is the most consistently overexpressed miRNA in almost...
-
Novel nomogram to predict biochemical recurrence-free survival after radical prostatectomy
PurposeConditional survival represents the probability of subsequent survival given that patients have already survived a certain length of time....
-
Progression-free survival on endocrine therapy, before or after chemotherapy, in hormone receptor-positive HER2-negative metastatic breast cancer
PurposeA major question when treating HR+/HER2− metastatic breast cancer (MBC) is whether early introduction of chemotherapy (CT) increases endocrine...
-
Radiologic-pathologic correlation of interstitial lung abnormalities and predictors for progression and survival
ObjectivesTo evaluate radiologic and histologic correlations for interstitial lung abnormalities (ILAs) and to investigate radiologic or pathologic...
